TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs
Clinical trial NCT07748728 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748728
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-14
- Primary completion
- 2027-07-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.